Gabriela Velazquez-Ramirez
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mesenteric Artery, Superior | 1 | 2016 | 9 | 0.560 |
Why?
|
Celiac Artery | 1 | 2016 | 6 | 0.560 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2016 | 12 | 0.560 |
Why?
|
Angioplasty, Balloon | 1 | 2016 | 35 | 0.550 |
Why?
|
Lower Extremity | 4 | 2018 | 100 | 0.500 |
Why?
|
Hand Strength | 2 | 2020 | 101 | 0.320 |
Why?
|
Vascular Diseases | 2 | 2020 | 66 | 0.320 |
Why?
|
Vascular Patency | 3 | 2017 | 69 | 0.310 |
Why?
|
Saphenous Vein | 2 | 2017 | 20 | 0.280 |
Why?
|
Vascular Surgical Procedures | 2 | 2019 | 88 | 0.180 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 297 | 0.170 |
Why?
|
Risk Factors | 5 | 2020 | 3876 | 0.160 |
Why?
|
Computer-Assisted Instruction | 1 | 2019 | 23 | 0.160 |
Why?
|
Patient Discharge | 1 | 2020 | 188 | 0.160 |
Why?
|
Amputation | 1 | 2018 | 38 | 0.160 |
Why?
|
Retrospective Studies | 5 | 2020 | 3509 | 0.160 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 86 | 0.150 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 127 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2017 | 19 | 0.150 |
Why?
|
Aged | 8 | 2020 | 10301 | 0.150 |
Why?
|
Marital Status | 1 | 2017 | 23 | 0.150 |
Why?
|
Students, Medical | 1 | 2019 | 131 | 0.140 |
Why?
|
Sarcopenia | 1 | 2017 | 64 | 0.140 |
Why?
|
Retreatment | 1 | 2016 | 41 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 46 | 0.140 |
Why?
|
Heart Diseases | 1 | 2017 | 116 | 0.140 |
Why?
|
Treatment Outcome | 4 | 2017 | 3306 | 0.130 |
Why?
|
Recurrence | 1 | 2016 | 263 | 0.130 |
Why?
|
Health Status Disparities | 1 | 2016 | 122 | 0.130 |
Why?
|
Stents | 1 | 2016 | 177 | 0.120 |
Why?
|
Internship and Residency | 1 | 2019 | 313 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2020 | 780 | 0.120 |
Why?
|
Chronic Disease | 1 | 2016 | 406 | 0.120 |
Why?
|
Male | 9 | 2020 | 19165 | 0.120 |
Why?
|
Female | 9 | 2020 | 19959 | 0.120 |
Why?
|
Time Factors | 2 | 2017 | 2149 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2017 | 684 | 0.120 |
Why?
|
Middle Aged | 6 | 2018 | 11817 | 0.110 |
Why?
|
Incidental Findings | 1 | 2012 | 25 | 0.100 |
Why?
|
Cholecystectomy | 1 | 2012 | 22 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2012 | 34 | 0.100 |
Why?
|
Aged, 80 and over | 2 | 2017 | 3990 | 0.100 |
Why?
|
Humans | 9 | 2020 | 32005 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 1428 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 1497 | 0.080 |
Why?
|
Cause of Death | 2 | 2020 | 236 | 0.080 |
Why?
|
Comorbidity | 2 | 2017 | 566 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 876 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2020 | 2265 | 0.060 |
Why?
|
Prospective Studies | 2 | 2020 | 2282 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 781 | 0.050 |
Why?
|
Sex Factors | 2 | 2016 | 663 | 0.050 |
Why?
|
Writing | 1 | 2019 | 13 | 0.040 |
Why?
|
Information Dissemination | 1 | 2019 | 52 | 0.040 |
Why?
|
Muscle Strength Dynamometer | 1 | 2017 | 11 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 33 | 0.040 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 143 | 0.040 |
Why?
|
Survival Rate | 1 | 2020 | 877 | 0.040 |
Why?
|
Frail Elderly | 1 | 2017 | 68 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 24 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 183 | 0.040 |
Why?
|
Curriculum | 1 | 2019 | 213 | 0.040 |
Why?
|
Linear Models | 1 | 2017 | 447 | 0.030 |
Why?
|
Age Factors | 1 | 2020 | 1188 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2016 | 46 | 0.030 |
Why?
|
Odds Ratio | 1 | 2017 | 472 | 0.030 |
Why?
|
Blood Glucose | 1 | 2018 | 494 | 0.030 |
Why?
|
Registries | 1 | 2017 | 298 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 353 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2017 | 390 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 399 | 0.030 |
Why?
|
Adult | 2 | 2019 | 9345 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 753 | 0.030 |
Why?
|
Prevalence | 1 | 2017 | 981 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1531 | 0.030 |
Why?
|
North Carolina | 1 | 2017 | 1514 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 918 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 2636 | 0.020 |
Why?
|
United States | 1 | 2020 | 3939 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 220 | 0.020 |
Why?
|
Survival Analysis | 1 | 2012 | 483 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2012 | 447 | 0.020 |
Why?
|